BANK OF AMERICA CORP /DE/ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,857,283
+6.2%
194,885
-2.0%
0.00%0.0%
Q2 2023$9,282,859
+4.8%
198,819
-14.1%
0.00%0.0%
Q1 2023$8,854,167
-20.2%
231,421
+14.3%
0.00%0.0%
Q4 2022$11,090,917
+363.3%
202,389
+187.8%
0.00%
Q3 2022$2,394,000
+559.5%
70,320
+82.8%
0.00%
Q2 2022$363,000
-58.9%
38,478
-38.2%
0.00%
Q1 2022$883,000
+4.9%
62,241
+56.4%
0.00%
Q4 2021$842,000
-30.3%
39,789
-26.4%
0.00%
Q3 2021$1,208,000
+456.7%
54,049
+517.7%
0.00%
Q2 2021$217,000
-29.5%
8,750
-17.7%
0.00%
Q1 2021$308,000
+58.8%
10,638
+41.2%
0.00%
Q4 2020$194,000
-80.4%
7,532
-76.6%
0.00%
Q3 2020$991,000
+348.4%
32,196
+262.8%
0.00%
Q2 2020$221,000
+281.0%
8,875
+222.8%
0.00%
Q1 2020$58,000
-56.1%
2,749
-53.9%
0.00%
Q4 2019$132,000
+187.0%
5,958
+203.8%
0.00%
Q3 2019$46,0001,9610.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders